These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 35145604)

  • 1. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.
    Jones DH; Bansal P; Bernstein JA; Fatteh S; Harper J; Hsu FI; O'Connor M; Park N; Suez D
    World Allergy Organ J; 2022 Jan; 15(1):100621. PubMed ID: 35145604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
    Valerieva A; Staevska MT; Grivcheva-Panovska V; Jesenak M; Kőhalmi KV; Hrubiskova K; Zanichelli A; Bellizzi L; Relan A; Hakl R; Farkas H
    World Allergy Organ J; 2021 Apr; 14(4):100535. PubMed ID: 33995818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the long-term prevention of hereditary angioedema attacks.
    Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA; Tyson C; Relan A; Adams P; Magar R
    J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
    Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
    Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable.
    Longhurst HJ; Valerieva A
    J Asthma Allergy; 2023; 16():269-277. PubMed ID: 36922963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hereditary angioedema-single or multiple pathways to the rescue.
    Valerieva A; Longhurst HJ
    Front Allergy; 2022; 3():952233. PubMed ID: 36172291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
    J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns.
    Riedl MA; Danese M; Danese S; Ulloa J; Maetzel A; Audhya PK
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2450-2456.e6. PubMed ID: 36720386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
    Li HH; Reshef A; Baker JW; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Veszeli N; Zotter Z; Szabó E; Varga L
    Allergy Asthma Proc; 2014; 35(3):255-9. PubMed ID: 24801469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
    Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.